Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics.

Georges ChehadeTévi Morel LawsonJulie LelotteLina DaoudDario Di PerriNicolas WhenhamThierry DuprezNicolas TajeddineFadel TissirChristian Raftopoulos

Published in: Acta neurochirurgica (2023)

We suggest that glioblastoma patients with a combination of favorable prognostic factors can achieve LTS in 74% of cases. In addition, methylome analysis is important to ascertain the type of glioma in LTS patients, especially when the MGMT promoter is unmethylated.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
dna methylation
peritoneal dialysis
transcription factor
low grade
patient reported